Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Methylene Blue as a Cerebral Metabolic and Hemodynamic Enhancer
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Methylene Blue as a Cerebral Metabolic and Hemodynamic Enhancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alzheimer's Disease
25%
Anterior Cingulate Cortex
12%
Brain Hemodynamics
25%
Brain Metabolism
25%
Brain Mitochondrial Function
12%
Cerebral Blood Flow
37%
Cerebral Glucose Metabolism
12%
Cerebral Hemodynamics
100%
Cerebral Oxygenation
12%
CMRO2
25%
Cortex Area
12%
Frontoparietal Cortex
12%
Glucose Uptake
37%
Hippocampus
12%
HT22 Cells
12%
Hypoxic Condition
25%
Isolated Mitochondria
12%
Magnetic Resonance Imaging
25%
Metabolic
100%
Metabolic Enhancer
12%
Methylene Blue
100%
Mitochondrial Complex I
12%
Mitochondrial Cytochrome c Oxidase
12%
Mitochondrial Function
12%
Motor Cortex
12%
Multi-metric
12%
Neuroimaging
25%
Neurological Disorders
12%
Neuroprotectant
12%
Non-destructive
12%
Normoxic Conditions
25%
Oxygen Consumption
25%
Parkinson's Disease
25%
Positron Emission Tomography
12%
Treatment Efficacy
12%
Medicine and Dentistry
Alzheimer's Disease
25%
Brain Blood Flow
37%
Brain Metabolism
25%
Carbene
100%
Combination Therapy
12%
Cytochrome C Oxidase
12%
Enhancer Region
100%
Frontoparietal Cortex
12%
Glucose Uptake
50%
Hemodynamic
100%
Hippocampus
12%
In Vitro
25%
Magnetic Resonance Imaging
25%
Metabolic Rate
12%
Mitochondrion
12%
Neurologic Disease
12%
Oxygen Consumption
25%
Parkinson's Disease
25%
Positron Emission Tomography
12%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
12%
Neuroscience
Alzheimer's Disease
25%
Brain Metabolism
25%
Cytochrome C Oxidase
12%
Enhancer Region
100%
Glucose Transport
50%
Hippocampus
12%
In Vitro
25%
In Vivo
25%
Magnetic Resonance Imaging
25%
Methylene Blue
100%
Mitochondrial Function
25%
Mitochondrion
12%
NADH Dehydrogenase (Ubiquinone)
12%
Neurological Disorder
12%
Parkinson's Disease
25%
Positron Emission Tomography
12%